Enzolytics (PK) Stock Price

-0.0017 (-2.98%)
Volume 1,835,080
Bid Price 0.0553
Ask Price 0.0571
News -
Day High 0.0598


52 Week Range


Day Low 0.055
Company Name Stock Ticker Symbol Market Type
Enzolytics Inc (PK) ENZC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0017 -2.98% 0.0553 13:23:21
Open Price Low Price High Price Close Price Prev Close
0.0571 0.055 0.0598 0.057
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
153 1,835,080 $ 0.056505 $ 103,691 - 0.0532 - 0.2075
Last Trade Time Type Quantity Stock Price Currency
13:23:25 41,250 $ 0.0553 USD


Draw Mode:

Enzolytics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 157.58M 2.83B -1.98B $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.51M $ - - - -

more financials information »

Enzolytics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENZC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.05860.05980.05350.05602134,660,088-0.0033-5.63%
1 Month0.0630.0645250.05350.05793144,753,761-0.0077-12.22%
3 Months0.060.0750.05350.06235455,368,375-0.0047-7.83%
6 Months0.09050.09990.05320.07061197,122,591-0.0352-38.9%
1 Year0.1420.20750.05320.106535211,031,519-0.0867-61.06%
3 Years0.0010.9580.00010.072801638,831,2390.05435,430.0%
5 Years0.0180.9580.00010.071857329,220,5820.0373207.22%

Enzolytics (PK) Description

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now